GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)

Verified July 2026: GLP-1 medications, Wegovy, Zepbound, Ozempic, Mounjaro, and Foundayo, cost between $25 and $1,350 per month across the 53-provider audit then live. With a manufacturer savings card + commercial insurance, eligible patients may pay $25/month for some brands, subject to program terms. Without insurance: Embody advertises compounded semaglutide from $79 on a selected plan, Enhance MD advertises $49 first month ($212/mo after) for compounded semaglutide or $99 first month ($280/mo after) for compounded tirzepatide, Foundayo starts at $149/mo at the 0.8 mg strength via LillyDirect, and Sprout Health starts at $199 first month ($249/mo after) for telehealth with both brand and compounded options plus a dedicated care coordinator. Foundayo rises to $199 at 2.5 mg and $299 at 5.5 mg or 9 mg; 14.5 mg and 17.2 mg remain $299 only when refilled within 45 days, otherwise $349. The manufacturer-direct snapshot was re-checked in August: NovoCare listed the Wegovy pen at $199/month for the first two low-dose fills, then $349/month at standard strengths ($399 for HD) and pill from $149/month, prescription required and dose-dependent; LillyDirect listed Zepbound from $299/month, with higher-dose pricing under its stated refill terms. Medicare Part D beneficiaries get $50/month via the GLP-1 Bridge program live as of July 1, 2026.

Quick answer by scenario: Have commercial insurance that covers Wegovy/Zepbound/Foundayo → apply the savings card, pay $25/mo if eligible and within the offer terms. Uninsured and want a low advertised cash-pay entry → Embody (semaglutide from $79 on a selected plan) or Enhance MD ($49 first month, then $212/mo semaglutide). Uninsured and want a brand-name pill → Foundayo at $149/mo (lowest dose) via LillyDirect. Uninsured and want brand-name injectable → LillyDirect ($299/mo Zepbound) or NovoCare Wegovy ($199/mo for the first two low-dose fills, then $349/mo at standard strengths or $399 HD). Uninsured and want comprehensive clinical oversight → Sprout Health $199 first month, then $249/mo includes a dedicated care coordinator, published 12-15% body weight loss outcomes at 6 months, and an established 2022+ operating track record. Medicare beneficiary → the GLP-1 Bridge program may cover eligible weight-management use at $50/mo. Use our cost calculator to estimate your monthly spend, see all providers sorted by lowest price, or take the 60-second match quiz.

This guide breaks down every pricing option: brand-name list prices, manufacturer direct-to-consumer programs (LillyDirect, NovoCare), the new Foundayo oral pill (see all oral GLP-1 pills compared), compounded telehealth providers, savings cards, Medicare/Medicaid coverage, and how the savings structures actually work. All prices verified July 2026 against provider websites and manufacturer announcements. Sources: CMS GLP-1 Bridge Demonstration, Zepbound savings card terms, Wegovy savings offer, Foundayo savings card.

How Much Do GLP-1 Medications Cost Without Insurance?

List prices (what pharmacies charge before discounts) don't reflect what most people pay. Here's the full picture:

How Do GLP-1 Savings Cards Work?

Both major manufacturers offer significant savings cards. These are the most impactful way to reduce your cost if you have commercial insurance:

Novo Nordisk (Wegovy, Ozempic, Saxenda): If you have commercial insurance that covers your medication, savings cards can bring your copay down to $25 per fill, subject to eligibility and program terms. For cash-pay patients, NovoCare listed the Wegovy pen at $199/month for the first two low-dose fills, then $349/month at standard strengths ($399 for HD) and oral pill from $149/month when checked August 7, 2026; a prescription is required and pricing is dose-dependent. Novo's March 31 launch included separate multi-month Wegovy offers at $249 to $329/month for the injection and $249 to $289/month for the pill through participating partners. Those dated launch terms should not be substituted for the current manufacturer-direct floor. Text SAVE to 83757 for a digital savings card.

Eli Lilly (Zepbound, Mounjaro, Foundayo): Eligible commercially insured patients may qualify for copays as low as $25 per fill under each program's terms. If insurance does not cover Zepbound, its savings-card price may be $499/month. LillyDirect lists self-pay Zepbound from $299 to $449/month depending on dose and refill terms. For Foundayo, LillyDirect lists $149/month at 0.8 mg, $199 at 2.5 mg, $299 at 5.5 mg or 9 mg, and $299 at 14.5 mg or 17.2 mg only when refilled within 45 days, otherwise $349. Check the current Foundayo savings-card terms and the medication-specific expiration and eligibility rules before relying on a copay figure.

Does Medicare Cover GLP-1 Medications?

This is the biggest cost development of 2026. CMS launched the Medicare GLP-1 Bridge Demonstration on July 1, 2026:

• •Beneficiary copay: $50/month for GLP-1 medications
• •Negotiated manufacturer price: $245/month (paid by the program)
• •Covers Wegovy, Zepbound (KwikPen only), and Foundayo
• •Eligibility: Medicare Part D enrollees meeting BMI criteria and related health conditions
• •Estimated ~10% of Medicare beneficiaries expected to qualify

The longer-term BALANCE Model is set to launch in January 2027 for Medicare and May 2026 for state Medicaid agencies that opt in. This combines GLP-1 access with lifestyle supports and allows CMS to negotiate drug pricing on behalf of participating plans.

Does Insurance Cover GLP-1 Medications for Weight Loss?

Insurance coverage for GLP-1s is actually getting more restrictive for weight loss in 2026, despite growing demand:

• •8.5% of commercially insured people (16+ million) have no GLP-1 coverage for weight loss at all
• •The number of people without Wegovy coverage specifically increased 42% vs 2025, over 41 million without access
• •Major insurers including BCBS, Cigna, and UnitedHealthcare implemented new restrictions as of January 2026, mostly limiting coverage to Type 2 diabetes only
• •Most insurers still cover Ozempic/Mounjaro for diabetes, restrictions primarily hit weight-loss-only indications

How Much Do Telehealth GLP-1 Programs Cost?

Online telehealth providers often offer lower total costs by bundling consultation fees with medication. Here's a sample of what platforms charge:

We rank 54 telehealth GLP-1 providers by price, see the full list sorted cheapest-first, or take the 60-second match quiz to find the best provider for your insurance, budget, and medication preference. For tirzepatide specifically, see our cheapest tirzepatide page.

Can You Use FSA or HSA for GLP-1 Medications?

GLP-1 medications are FSA and HSA eligible when prescribed for a documented medical condition (obesity, Type 2 diabetes, metabolic syndrome). This applies to all brand-name GLP-1s, compounded versions with a valid prescription, and in many cases the telehealth consultation fees as well. You'll need a valid prescription and medical documentation, purely cosmetic weight loss without a medical diagnosis may not qualify.

Does Medicaid Cover GLP-1 Medications?

As of January 2026, only 13 state Medicaid fee-for-service programs cover GLP-1s for obesity treatment, down from 16. California, New Hampshire, Pennsylvania, and South Carolina recently eliminated coverage. Michigan added strict requirements including morbid obesity classification and documented failure of other interventions.

The BALANCE Model allows state Medicaid agencies to opt in starting May 2026, with CMS negotiating drug pricing on their behalf. This could expand access, but it's voluntary.